Biomarkers of Response or Resistance to Ribociclib + Endocrine Therapy for Advanced Breast Cancer: Pooled Analysis of MONALEESA Phase III Trials

May 29-31, 2020; Online at meetings.asco.org/am
In this pooled analysis of ctDNA from 3 MONALEESA breast cancer studies, multiple potential biomarkers of ribociclib sensitivity and resistance were identified.
Format: Microsoft PowerPoint (.ppt)
File Size: 232 KB
Released: May 31, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
GlaxoSmithKline
Merck Sharp & Dohme Corp
Novartis Pharmaceuticals Corporation

Related Content

In this slideset from Clinical Care Options (CCO), experts provide insights on HER2 testing and resulting implications for treatment in breast cancer

Mark D. Pegram, MD Michael F. Press, MD, PhD Released: July 30, 2020

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on HER2 testing in metastatic breast cancer

Mark D. Pegram, MD Michael F. Press, MD, PhD Released: July 30, 2020

From Clinical Care Options (CCO), download this PDF summarizing HER2, HER3, and TROP2 testing and targeted therapeutics

Mark D. Pegram, MD Michael F. Press, MD, PhD Released: July 30, 2020

A living slideset on optimal management of breast cancer during the COVID-19 pandemic that will be updated as the situation evolves and new data emerge

Harold J. Burstein, MD, PhD Hope S. Rugo, MD Released: July 28, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?